We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+17.45%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$9.03B
AUM Growth
-$1.37B
(-13%)
Cap. Flow
-$2.48B
Cap. Flow
% of AUM
-27.43%
Top 10 Holdings %
Top 10 Hldgs %
18.31%
Holding
2,015
New
576
Increased
314
Reduced
307
Closed
636
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SKX
Skechers
SKX
|
+$18.3M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$17.4M |
| 3 |
Insmed
INSM
|
+$16.1M |
| 4 |
Gilead Sciences
GILD
|
+$15.8M |
| 5 |
K
Kellanova
K
|
+$15.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$394M |
| 2 |
Amazon
AMZN
|
+$314M |
| 3 |
NVIDIA
NVDA
|
+$255M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$121M |
| 5 |
Advanced Micro Devices
AMD
|
+$61.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.09% |
| 2 | Consumer Discretionary | 2.5% |
| 3 | Technology | 1.62% |
| 4 | Financials | 1.05% |
| 5 | Communication Services | 0.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Matthews International
MATW
$866M
| $215K | ﹤0.01% |
+9,000
| New | +$190K |
|
|
ODV
1252
CALL
DELISTED
Osisko Development Corp
ODV
| $214K | ﹤0.01% |
+100,000
| New | +$185K |
|
1253
IDEAYA Biosciences
IDYA
$3.42B
| $210K | ﹤0.01% |
+10,000
| New | +$192K |
|
|
NNDM
1254
Nano Dimension
NNDM
$316M
| $210K | ﹤0.01% |
129,437
-56,000
| -30% | -$85.7K |
|
1255
Procore
PCOR
$8.26B
| $205K | ﹤0.01% |
3,000
-3,621
| -55% | -$236K |
|
1256
Daktronics
DAKT
$955M
| $204K | ﹤0.01% |
13,507
-1,193
| -8% | -$16.4K |
|
1257
CALL
Recursion Pharmaceuticals
RXRX
$1.59B
| $202K | ﹤0.01% |
40,000
| – | – |
|
1258
CALL
Vir Biotechnology
VIR
$1.46B
| $202K | ﹤0.01% |
40,000
| – | – |
|
|
1259
PUT
Vir Biotechnology
VIR
$1.46B
| $202K | ﹤0.01% |
40,000
| – | – |
|
1260
SoundThinking
SSTI
$100M
| $201K | ﹤0.01% |
15,389
-177
| -1% | -$2.76K |
|
1261
Applied Optoelectronics
AAOI
$7.57B
| $195K | ﹤0.01% |
7,600
-2,400
| -24% | -$38.8K |
|
1262
Brown-Forman Class B
BF.B
$13.2B
| $194K | ﹤0.01% |
+7,200
| New | +$231K |
|
1263
Baker Hughes
BKR
$60B
| $192K | ﹤0.01% |
5,000
-12,150
| -71% | -$458K |
|
|
CRON
1264
CALL
Cronos Group
CRON
$1.06B
| $191K | ﹤0.01% |
100,000
-135,000
| -57% | -$256K |
|
|
VG
1265
Venture Global Inc
VG
$33.2B
| $189K | ﹤0.01% |
12,140
-3,460
| -22% | -$40K |
|
1266
CALL
O-I Glass
OI
$1.1B
| $187K | ﹤0.01% |
12,700
-37,300
| -75% | -$477K |
|
|
SHCO
1267
DELISTED
Soho House & Co
SHCO
| $187K | ﹤0.01% |
+25,426
| New | +$158K |
|
1268
Amplify Junior Silver Miners ETF
SILJ
$3.18B
| $185K | ﹤0.01% |
12,500
-12,500
| -50% | -$163K |
|
1269
Alkermes
ALKS
$8.22B
| $185K | ﹤0.01% |
6,460
-64,887
| -91% | -$1.93M |
|
1270
Equinox Gold
EQX
$7.06B
| $184K | ﹤0.01% |
32,000
-5,000
| -14% | -$32.5K |
|
1271
Acadia Pharmaceuticals
ACAD
$4.43B
| $182K | ﹤0.01% |
8,455
-56,769
| -87% | -$1.06M |
|
1272
CALL
BioCryst Pharmaceuticals
BCRX
$2.28B
| $179K | ﹤0.01% |
+20,000
| New | +$186K |
|
|
1273
PUT
BioCryst Pharmaceuticals
BCRX
$2.28B
| $179K | ﹤0.01% |
+20,000
| New | +$186K |
|
1274
CALL
Target Hospitality
TH
$1.51B
| $178K | ﹤0.01% |
+25,000
| New | +$174K |
|
1275
Ecovyst
ECVT
$1.32B
| $176K | ﹤0.01% |
+21,400
| New | +$150K |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2025 Portfolio in Review
As of Q2 2025, Caption Management held 2,015 positions worth $9.03B, down 13% from $10.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Caption Management withdrew a net $2.48B in Q2 2025, closing 636 positions and reducing 307 holdings. Its most notable exit was Microsoft, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 1.5% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Caption Management opened a new position in Skechers worth $20.1M.
- Caption Management's largest Q2 2025 buy was Skechers: 317,932 shares worth $20.1M.
- Caption Management added most to Kellanova in Q2 2025, an estimated $15.3M increase.
- Caption Management's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $121M.
- Caption Management fully exited Microsoft in Q2 2025, selling an estimated $394M.
- Caption Management's ten largest holdings make up 18% of its $9.03B portfolio in Q2 2025.
- Caption Management opened 576 new positions and closed 636 in Q2 2025.
- Caption Management's portfolio value fell 13% quarter-over-quarter to $9.03B.
Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.